跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
Revefore NMN 18000
Approved
STANDARD
Revefore NMN 18000
Walve Biotech Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
bc7e3298259cc7b1
Company
Walve Biotech Pty Ltd
Type
Standard
Approval Details
Approval Id
bc7e3298259cc7b1
Product Name
Revefore NMN 18000
Artg Id
466306
Artg Name
Revefore NMN 18000
Sponsor
Walve Biotech Pty Ltd
Company Detail Path
/organization/walve-biotech-pty-ltd
Artg Date
2024-10-29
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LIE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
bc7e3298259cc7b1
Type
Standard
Back to TGA Approvals
Revefore NMN 18000 - TGA Drug Approval Details